Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-25 @ 2:41 PM
NCT ID: NCT01373450
Description: None
Frequency Threshold: 5
Time Frame: Up to 14 days after last dose of study medication
Study: NCT01373450
Study Brief: Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Oxyntomodulin Oxyntomodulin 3.0 pmol/kg/min IV infusion None None 0 12 6 12 View
Liraglutide 0.6 mg Liraglutide 0.6 mg subcutaneous None None 0 12 7 12 View
Liraglutide 1.2 mg Liraglutide 1.2 mg subcutaneous None None 0 6 1 6 View
Placebo Placebo for Oxyntomodulin IV infusion and Placebo for Liraglutide subcutaneous None None 0 12 8 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Salivary Hypersecretion None Gastrointestinal disorders MedDRA 15.0 View
Catheter Site Pain None General disorders MedDRA 15.0 View
Catheter Site Related Reaction None General disorders MedDRA 15.0 View
Dry Mouth None Gastrointestinal disorders MedDRA 15.0 View
Nausea None Gastrointestinal disorders MedDRA 15.0 View
Fatigue None General disorders MedDRA 15.0 View
Oedema Peripheral None General disorders MedDRA 15.0 View
Rhinitis None Infections and infestations MedDRA 15.0 View
Arthralgia None Musculoskeletal and connective tissue disorders MedDRA 15.0 View
Back Pain None Musculoskeletal and connective tissue disorders MedDRA 15.0 View
Musculoskeletal Stiffness None Musculoskeletal and connective tissue disorders MedDRA 15.0 View
Headache None Nervous system disorders MedDRA 15.0 View
Acne None Skin and subcutaneous tissue disorders MedDRA 15.0 View
Pruritis None Skin and subcutaneous tissue disorders MedDRA 15.0 View